DESIPRAMINE AND CONTINGENCY MANAGEMENT FOR COCAINE AND OPIATE DEPENDENCE IN BUPRENORPHINE MAINTAINED PATIENTS
Sparad:
KOSTEN, T., ET AL., DESIPRAMINE AND CONTINGENCY MANAGEMENT FOR COCAINE AND OPIATE DEPENDENCE IN BUPRENORPHINE MAINTAINED PATIENTS. DRUG AND ALCOHOL DEPENDENCE, Vol. 70, no. 3 (2003), p. 315-325.
Ref.
123849
Placering:
SIIS R.854 Archivo
Palabras clave:
Buprenorfina, Cocaína, Drogodependencias, Fármacos, Opiáceos, Poliuso de drogas, Programas de mantenimiento, Resultados
Buprenorfina, Cocaína, Drogodependencias, Fármacos, Opiáceos, Poliuso de drogas, Programas de mantenimiento, Resultados
Liknande verk: DESIPRAMINE AND CONTINGENCY MANAGEMENT FOR COCAINE AND OPIATE DEPENDENCE IN BUPRENORPHINE MAINTAINED PATIENTS
- DESIPRAMINE, AMANTADINE, OR FLUOXETINE IN BUPRENORPHINE-MAINTAINED COCAINE USERS
- DESIPRAMINE TREATMENT FOR COCAINE DEPENDENCE IN BUPRENORPHINE- OR METHADONE-TREATED PATIENTS: BASELINE URINE RESULTS AS PREDICTOR OF RESPONSE
- EFFECTS OF REDUCING CONTINGENCY MANAGEMENT VALUES ON HEROIN AND COCAINE USE FOR BUPRENORPHINE- AND DESIPRAMINE-TREATED PATIENTS
- DEPRESSION PREDICTS HIGHER RATES OF HEROIN USE ON DESIPRAMINE WITH BUPRENORPHINE THAN WITH METHADONE
- BUPRENORPHINE FOR DUAL DEPENDENCY: COCAINE, ALCOHOL AND OPIATES
- BUPRENORPHINE FOR OFFICE-BASED TREATMENT OF OPIATE DEPENDENCE: US AND INTERNATIONAL FIELD EXPERIENCE